Aug 2026· Science Translational Medicine· Vol 18 862, pp.
eaee5425
· 3 citations· 33 references
Medicine
TL;DR
Empitope valency and affinity worked in combination to promote GC B cell competitive fitness, although valency had prominent influences, and both valency and affinity regulated the early extrafollicular plasma cell response in a manner dependent on interclonal competition.
Abstract
Vaccination with real-world complex antigens often elicits a hierarchical immune response to different epitopes. This immunodominance is a major obstacle in vaccine design because nonprotective epitopes often divert the immune response away from protective epitopes. We posited that B cell epitope avidity (i.e., total multivalent binding strength) is a key regulator of immunodominance hierarchy by modulating both germinal center (GC) seeding and B cell competitive fitness in GCs. To test these hypotheses, we used two sets of mosaic nanoparticle immunogens to precisely modulate epitope avidity by varying the valency and affinity components independently while keeping nanoparticle size and helper T cell epitopes constant. We evaluated these immunogens in three HIV vaccine models that use humanized mice to recapitulate physiological precursor frequencies and affinities. Increased epitope avidity drove seeding of GCs, as well as B cell competitive fitness and immunodominance hierarchies in GCs. B cell receptor sequencing revealed that epitope valency had negligible impact on total somatic hypermutations but collectively promoted clonal diversity and affinity maturation in GCs. Restricting interclonal competition rescued early GC B cell responses to low-valency immunogens. Epitope valency and affinity worked in combination to promote GC B cell competitive fitness, although valency had prominent influences. Furthermore, both valency and affinity regulated the early extrafollicular (EF) plasma cell response in a manner dependent on interclonal competition. The data highlight the critical importance of relative epitope avidity in shaping the competitive immunodominance landscape in GC and EF responses. This should be considered when designing next-generation nanoparticle vaccines.
Dengue virus remains a major global health threat due to its four antigenically diverse serotypes and limited treatment and vaccine options. This study aimed to design and evaluate a rational tetravalent multi-epitope vaccine capable of eliciting broad cross-serotype immune responses against dengue virus. An immunoinfo...
Theerawat Dobutr, Pemikar Srifa, N. Pinpathomrat· Frontiers in Cellular and In...· 0 citations
Together, these examples show that what antibody repertoires “see” is determined by the interplay between viral glycoprotein structure, B cell precursor availability, somatic evolution, and population‐level immunoglobulin diversity.
Bruno Bonnettaz, G. Bajic· Immunological Reviews· 0 citations
mRNA vaccines can encode multiple tumor antigens whose presentation ultimately depends on adequate intracellular processing. To evaluate the potential impact of epitope-flanking sequences, we compared the immunogenicity of two mRNA vaccines in the MC38 mouse model. Both vaccines coded for the same tumor-specific antige...
Marie-Pierre Hardy, Gabriel Ouellet-Lavallée, Catherine Thériault et al.· Cells· 0 citations
An effective HIV-1 vaccine will likely require broadly neutralizing antibodies (bnAbs) targeting multiple complementary epitopes on the Envelope (Env) glycoprotein. Donor-derived bnAbs targeting the conserved silent face (SF) epitope complement established bnAb classes, but the maturation pathways underlying SF bnAb de...
Joshua J. Carter, M. B. Palacio, Mark E. Berlaga et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.